CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells

Overview of attention for article published in Frontiers in immunology, November 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 11 X users

patent: 4 patents

Citations

dimensions_citation: 38 Dimensions

Readers on

mendeley: 60 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

ANTI-CD38 ANTIBODIES, ANTI-CD3 ANTIBODIES, AND BISPECIFIC ANTIBODIES, AND USES THEREOF

Application WO-2023015170-A2

World Intellectual Property Organisation (WIPO)

ANTI-CD38 ANTIBODIES AND EPITOPES OF SAME

Application WO-2022271987-A1

World Intellectual Property Organisation (WIPO)

Heavy chain antibodies that bind to CD38

Application CN-115023441-A

China

HEAVY CHAIN ANTIBODIES BINDING TO CD38

Application WO-2021127489-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.